Free Trial

Artiva Biotherapeutics (ARTV) SEC Filings & 10K Form

Artiva Biotherapeutics logo
$10.96 -0.34 (-3.01%)
(As of 11/20/2024 ET)

Recent Artiva Biotherapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
3:56 PM
Artiva Biotherapeutics (Subject)
venBio Global Strategic Fund III, L.P. (Filed by)
Form SC 13G/A
10/22/2024
7:14 PM
Artiva Biotherapeutics (Issuer)
MOORE ALISON (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/22/2024
7:18 PM
Artiva Biotherapeutics (Issuer)
MOORE ALISON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
3:13 PM
Artiva Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2024
3:16 PM
Artiva Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
6:00 PM
Artiva Biotherapeutics (Subject)
venBio Global Strategic Fund III, L.P. (Filed by)
Form SC 13G
08/01/2024
3:17 PM
5AM Ventures VI, L.P. (Filed by)
Artiva Biotherapeutics (Subject)
Form SC 13G
08/01/2024
3:18 PM
Artiva Biotherapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G
07/29/2024
3:29 PM
Artiva Biotherapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D
07/29/2024
3:15 PM
Artiva Biotherapeutics (Subject)
GC Corp. (Filed by)
Form SC 13D
07/24/2024
3:27 PM
Artiva Biotherapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
3:15 PM
5AM Opportunities II , LLC (0001873515) (Reporting)
5AM Opportunities II, L.P. (Reporting)
5AM Partners VI, LLC (Reporting)
5AM Ventures VI, L.P. (Reporting)
Artiva Biotherapeutics (Issuer)
PARMAR KUSH (Reporting)
Schwab Andrew J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
7:18 PM
Artiva Biotherapeutics (Issuer)
Aslan Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
7:22 PM
Artiva Biotherapeutics (Issuer)
Huh Yong-Jun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
7:25 PM
Artiva Biotherapeutics (Issuer)
GC Cell Corp (Reporting)
GC Corp. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
7:26 PM
Adelman Robert J (Reporting)
Artiva Biotherapeutics (Issuer)
GOODMAN COREY S (Reporting)
venBio Global Strategic Fund III, L.P. (Reporting)
VENBIO GLOBAL STRATEGIC GP III, L.P. (Reporting)
VENBIO GLOBAL STRATEGIC GP III, LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
7:28 PM
Artiva Biotherapeutics (Issuer)
Wellington Biomedical Innovation Master Investors I L.P. (0001787092) (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
4:30 PM
Artiva Biotherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/22/2024
3:19 PM
Artiva Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
11:15 PM
Artiva Biotherapeutics (Filer)
Form EFFECT
07/18/2024
7:14 PM
Adelman Robert J (Reporting)
Artiva Biotherapeutics (Issuer)
GOODMAN COREY S (Reporting)
venBio Global Strategic Fund III, L.P. (Reporting)
VENBIO GLOBAL STRATEGIC GP III, L.P. (Reporting)
VENBIO GLOBAL STRATEGIC GP III, LTD (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
7:00 PM
Artiva Biotherapeutics (Issuer)
Aslan Fred (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
7:00 PM
Artiva Biotherapeutics (Issuer)
Bush Jennifer (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
7:01 PM
Artiva Biotherapeutics (Issuer)
Horan Christopher (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
7:01 PM
Artiva Biotherapeutics (Issuer)
Krishnamohan Neha (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
7:01 PM
Artiva Biotherapeutics (Issuer)
Graef Thorsten (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
7:02 PM
Artiva Biotherapeutics (Issuer)
Bessen Laura (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
7:02 PM
Artiva Biotherapeutics (Issuer)
Huh Yong-Jun (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
7:02 PM
Artiva Biotherapeutics (Issuer)
Raymon Heather (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
7:03 PM
Artiva Biotherapeutics (Issuer)
DANIELS BRIAN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
7:04 PM
Artiva Biotherapeutics (Issuer)
HOUGEN ELIZABETH L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
7:05 PM
Artiva Biotherapeutics (Issuer)
GC Cell Corp (Reporting)
GC Corp. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
7:05 PM
Artiva Biotherapeutics (Issuer)
Stoppel Laura (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
7:06 PM
Artiva Biotherapeutics (Issuer)
Wellington Biomedical Innovation Master Investors I L.P. (0001787092) (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
7:06 PM
Artiva Biotherapeutics (Issuer)
Miralles Gines Diego (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
7:06 PM
5AM Partners VI, LLC (Reporting)
5AM Ventures VI, L.P. (Reporting)
Artiva Biotherapeutics (Issuer)
PARMAR KUSH (Reporting)
Schwab Andrew J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
7:08 PM
Artiva Biotherapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
4:55 PM
Artiva Biotherapeutics (Filer)
Form S-1MEF
07/15/2024
5:07 AM
Artiva Biotherapeutics (Filer)
Form S-1/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ARTV) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners